02 September 2022 | NewsVideo now available | NCIRS webinar - Emerging vaccine preventable diseases and vaccination for travelRead the full article
This webinar was held as part of the 2021 NCIRS COVID-19 vaccine webinar series.
View the video of this webinar to:
Our expert panel members from Australia and the USA also answered several vaccine safety questions asked by the attendees.
Paul A. Offit, MD
Paul A. Offit, MD, is Director of the Vaccine Education Center and professor of pediatrics in the Division of Infectious Diseases at Children’s Hospital of Philadelphia. He is the Maurice R. Hilleman Professor of Vaccinology at the Perelman School of Medicine at the University of Pennsylvania.
Dr Offit is an internationally recognised expert in the fields of virology and immunology, and was a member of the Advisory Committee on Immunization Practices to the Centers for Disease Control and Prevention. He is a member of the Food and Drug Administration Vaccines and Related Biological Products Advisory Committee, and a founding advisory board member of the Autism Science Foundation and the Foundation for Vaccine Research, a member of the Institute of Medicine and co-editor of the foremost vaccine text, Vaccines. Dr Offit has published more than 150 papers in medical and scientific journals in the areas of rotavirus-specific immune responses and vaccine safety.
Associate Professor Nicholas Wood MBBS, MPH, FRACP, PhD
Associate Director, Clinical Research and Services, NCIRS
Senior Staff Specialist
Nicholas Wood is a staff specialist general paediatrician and Associate Professor and Academic Lead (Higher Degree Research) in the Discipline of Child and Adolescent Health at The University of Sydney. He holds an NHMRC Career Development Fellowship.
Nick leads the NSW Immunisation Specialist Service and coordinates the Immunisation Adverse Events Clinic at The Children's Hospital at Westmead. He is a senior investigator on the Primary Health network immunisation Support program. Nick is interested in maternal and neonatal immunisation, as well as research into vaccine safety, including genetics and long-term outcomes of adverse events following immunisation.